BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 5, 2004
View Archived Issues
Rosiglitazone inhibits keratinocyte proliferation
Read More
HMG-CoA reductase mediates the anticortisol effect of procaine
Read More
Novel CCK2B selective agonist with original pharmacological properties described
Read More
NHE exchanger inhibitor SM-20220 protective against excitotoxicity
Read More
Ampligen protects against coxsackie B3 virus-induced myocarditis
Read More
Acambis restructures and reprioritizes
Read More
Novel DPP-IV inhibitors under study at Sanofi-Synthelabo
Read More
U. of Tennessee researchers design new selective androgen receptor modulators
Read More
New 5-HT2C agonists for obesity and other disorders covered by Biovitrum patent
Read More
BMS team prepares and tests new anti-HIV agents
Read More
Aniline-based factor VIIa inhibitors newly identified at BMS
Read More
Two series of protein kinase modulators patented by Cellular Genomics
Read More
Takeda describes new prodrugs of proton pump inhibitors and their use
Read More
Sanofi-Synthelabo claims novel TNF-alpha production inhibitors for inflammation and pain
Read More
Bayer to distribute Testim in Canada
Read More
Shareholder approval of Genome Therapeutics/Genesoft merger
Read More
BioSante updates development progress
Read More
Registrational satraplatin trial expanded into Europe
Read More
Xcel acquires retigabine rights from Viatris
Read More
Caduet receives FDA approval
Read More
Roche and AEterna enter Brazilian marketing agreement for Impavido
Read More
Roll-out of Zyprexa
Read More
Positive preclinical results for GLP1-I.N.T
Read More
Treatment completed in phase II FM-VP4 trial
Read More
Development status of Arius antibodies
Read More
Bone Care International reports very productive Q2 FY2004
Read More
Altana sustains growth throughout 2003
Read More
Unacceptable safety profile found for HRT in breast cancer survivors
Read More
A phase II clinical trial shows no effects for repifermin in cancer therapy-induced mucositis
Read More
OrthoLogic continued progress with Chrysalin product platform during the past year
Read More
Merck & Co. highlights efforts to drive long-term growth in 2003
Read More
Cell Genesys reports developments of lead product candidate GVAX over past year
Read More
Kissei obtains marketing approval of Glufast in Japan
Read More